Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Contact Supplier

Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 875337-44-3, Mgcd-265, N-((3-fluoro-4-((2-(1-methyl-1h-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)carbamothioyl)-2-phenylacetamide, Mfcd17779287, Chembl254760, N-(3-fluoro-4-(2-(1-methyl-1h-imidazol-4-yl)thieno(3,2-b)pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide

Molecular Formula

C₂₆H₂₀FN₅O₂S₂

Molecular Weight

517.6 g/mol

InChI Key

UFICVEHDQUKCEA-UHFFFAOYSA-N

FDA UNII

93M6577H9D

1 2D Structure

N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide

2.1.2 InChI

InChI=1S/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-28-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-16/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35)

2.1.3 InChI Key

UFICVEHDQUKCEA-UHFFFAOYSA-N

2.2 Other Identifiers

2.2.1 UNII

93M6577H9D

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 875337-44-3

2. Mgcd-265

3. N-((3-fluoro-4-((2-(1-methyl-1h-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)carbamothioyl)-2-phenylacetamide

4. Mfcd17779287

5. Chembl254760

6. N-(3-fluoro-4-(2-(1-methyl-1h-imidazol-4-yl)thieno(3,2-b)pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide

7. 93m6577h9d

8. N-[[[3-fluoro-4-[[2-(1-methyl-1h-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]benzeneacetamide

9. Benzeneacetamide, N-(((3-fluoro-4-((2-(1-methyl-1h-imidazol-4-yl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)amino)thioxomethyl)-

10. N-[(3-fluoro-4-{[2-(1-methyl-1h-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)carbamothioyl]-2-phenylacetamide

11. N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide

12. C26h20fn5o2s2

13. Unii-93m6577h9d

14. Mls006010962

15. Orb1300844

16. Schembl3576588

17. Schembl29354555

18. Schembl29358763

19. Bdbm24498

20. Chebi:91393

21. Dtxsid60647874

22. Ex-a051

23. Hms3295e15

24. Hms3654p17

25. Nsc800790

26. S1361

27. Akos015904513

28. Ccg-269835

29. Cs-0188

30. Ff41064

31. Nsc-800790

32. Sdccgsbi-0654365.p001

33. Ncgc00346510-01

34. Ncgc00346510-04

35. 3-(3-fluoro-4-{[2-(1-methyl-1h-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-(2-phenylacetyl)thiourea

36. Ac-32063

37. As-75067

38. Hy-10991

39. Smr004702766

40. Sw219463-1

41. Thieno[3,2-b]pyridine-based Inhibitor, 10a

42. Brd-k56277358-001-01-8

43. Brd-k56277358-001-07-5

44. Q27077814

45. 1-(3-fluoro-4-{[2-(1-methyl-1h-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-3-(2-phenylacetyl)thiourea

46. N-(3-fluoro-4-{[2-(1-methyl-1h-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-n'-(phenylacetyl)thiourea

47. N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy-phenyl]carbamothioyl]-2-phenyl-acetamide

2.4 Create Date

2008-09-22

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₂₀FN₅O₂S₂
Molecular Weight	517.6 g/mol
XLogP3	4.9
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	6
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	141
Heavy Atom Count	36
Formal Charge	0
Complexity	773
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Find N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide manufacturers, exporters & distributors on PharmaCompass

N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

MARKET PLACE

DIGITAL CONTENT

What are you looking for?